Cannara Biotech Enhances U.S. Investor Access and Financial Health

Author: Ryan Hughes Updated: 10-07-2025 08:19 AM

Cannara Biotech Strengthens U.S. Presence and Financial Position

Cannara Biotech Inc. is thrilled to share that it has achieved DTC eligibility for its common shares, making it easier for U.S. investors to purchase and trade its stock. This vital move enhances the company's visibility in the competitive cannabis industry and opens the door to a broader network of brokerage firms.

The Significance of DTC Eligibility

DTC eligibility marks a significant milestone for Cannara as its shares can now be electronically cleared and settled within the U.S. This crucial step not only reduces transaction costs for U.S. investors but also improves the liquidity of Cannara's stock. Zohar Krivorot, the Founder and CEO, highlighted the importance of this achievement, stating it will broaden the company's shareholder base and strengthen its market presence.

Reducing Debt Burdens Through Strategic Moves

In addition to enhancing its marketplace accessibility, Cannara has successfully completed a debt-to-equity conversion, which is a pivotal move that bolsters its financial stability. The company issued 3,462,763 common shares to Olymbec Investments Inc. for approximately $6.2 million in owed debt.

Strengthening the Balance Sheet

This strategic conversion, executed at an issue price of $1.80 per share, primarily includes about $4.7 million in principal and approximately $1.5 million in accrued interest. Nicholas Sosiak, the CFO, expressed that this initiative will help Cannara reduce its leverage and enhance its liquidity while paving the way for future growth initiatives.

Future Potential and Clarifications

Moreover, the company has issued clarifications regarding stock options previously granted for investor relations services. The 40,000 options issued to Bristol Capital Ltd. will now be valid for four years, expiring on April 25, 2029, which ensures that stakeholders remain informed about the company’s commitments.

About Cannara Biotech Inc.

Cannara Biotech Inc. is a vertically integrated producer operating in the cannabis space, focusing on delivering premium-grade products at competitive prices. With two facilities in Quebec spanning over 1,650,000 sq. ft., it is well-positioned to produce approximately 100,000 kg of cannabis annually. This operational scale, combined with Quebec's low electricity costs, allows Cannara to maintain a leading edge in the market.

Frequently Asked Questions

What does DTC eligibility mean for Cannara Biotech?

DTC eligibility allows Cannara's shares to be traded through U.S. brokerage firms, leading to increased liquidity and accessibility for investors in the United States.

How does Cannara plan to use the funds from the debt-to-equity conversion?

The funds will be utilized to strengthen Cannara's balance sheet, reduce debt leverage, and provide liquidity for future growth strategies.

What are Cannara's primary products?

Cannara specializes in premium-grade cannabis products and aims to provide affordable yet quality options within the Canadian market.

What impact does this announcement have on potential investors?

The announcement of DTC eligibility and debt reduction might attract new investors, as it signifies a healthier financial position and greater market liquidity.

Who can I contact for more information about Cannara?

You can contact Nicholas Sosiak, CFO, at nick@cannara.ca or Zohar Krivorot, CEO, at zohar@cannara.ca for any inquiries.

About The Author

Hello, my name is Ryan Hughes. I am a financial, economics, and stock market specialist committed to assisting people in negotiating the intricacies of the financial system. Having a great deal of experience and a thorough grasp of market dynamics and economic trends, my area of expertise is converting complex financial ideas into understandable, practical knowledge. By use of my articles and blog entries, I hope to give you the information and assurance you need to make wise financial choices.

I've had the honor of interacting with a wide range of readers as a writer for several financial blogs, from new investors to seasoned market participants. To enable you to reach your financial goals, I want to make finance, economics, and stock market trends understandable and approachable. I appreciate you traveling with me toward success and financial literacy.

Contact Ryan Hughes privately here. Or send an email with ATTN: Ryan Hughes as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.